Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-16 | Julie Eastland Ms. Eastland was appointed to our Board in July 2020. ... Ms. Eastland received an M.B.A. from Edinburgh University Management School and a B.S. in finance from Colorado State University. She also serves on the boards of Harpoon Therapeutics and Graybug Vision. We believe that Ms. Eastland’s experience as a financial executive in the biopharmaceutical industry qualifies her to serve as a director. ... The following table shows for the fiscal year ended December 31, 2020, certain information with respect to the cash compensation of all non-employee directors of the Company: ... Julia M. Eastland Fees Earned or Paid in Cash $22,802, Option Awards $393,570, Total $416,372. |
| 2022-04-14 | Ms. Eastland has been a member of our Board since July 2020. Ms. Eastland has served as Chief Executive Officer of Harpoon Therapeutics, a publicly traded oncology company, since November 2021. ... Ms. Eastland received an M.B.A. from Edinburgh University Management School and a B.S. in finance from Colorado State University. She also serves on the boards of Harpoon Therapeutics and Graybug Vision. We believe that Ms. Eastland’s experience as a financial executive in the biopharmaceutical industry qualifies her to serve on our Board. |
| 2023-04-13 | Julie Eastland Ms. Eastland has been a member of our Board since July 2020. ... Our Board believes that Ms. Eastland’s experience as a financial executive in the biopharmaceutical industry qualifies her to serve on our Board. |
| 2024-04-11 | Julie Eastland Ms. Eastland has been a member of our Board since July 2020. ... Our Board believes that Ms. Eastlands experience as a financial executive in the biopharmaceutical industry qualifies her to serve on our Board. |
Data sourced from SEC filings. Last updated: 2026-03-05